1. Home
  2. ZLAB vs RVLV Comparison

ZLAB vs RVLV Comparison

Compare ZLAB & RVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$23.14

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Revolve Group Inc.

RVLV

Revolve Group Inc.

HOLD

Current Price

$24.94

Market Cap

1.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZLAB
RVLV
Founded
2013
2003
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
ZLAB
RVLV
Price
$23.14
$24.94
Analyst Decision
Strong Buy
Buy
Analyst Count
5
12
Target Price
$49.60
$29.73
AVG Volume (30 Days)
700.3K
665.2K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
38.46
24.64
EPS
N/A
0.86
Revenue
$460,156,000.00
$1,225,682,000.00
Revenue This Year
$9.75
$10.96
Revenue Next Year
$26.03
$8.01
P/E Ratio
N/A
$29.16
Revenue Growth
15.33
8.48
52 Week Low
$15.96
$16.80
52 Week High
$44.34
$31.68

Technical Indicators

Market Signals
Indicator
ZLAB
RVLV
Relative Strength Index (RSI) 73.24 56.52
Support Level $16.88 $20.56
Resistance Level $27.23 $26.65
Average True Range (ATR) 0.75 1.00
MACD 0.36 0.39
Stochastic Oscillator 98.15 75.27

Price Performance

Historical Comparison
ZLAB
RVLV

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About RVLV Revolve Group Inc.

Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.

Share on Social Networks: